Lifelong endocrine fluctuations and related cognitive disorders

被引:51
作者
Ancelin, ML
Ritchie, K
机构
[1] INSERM, E361, F-34093 Montpellier, France
[2] Univ Montpellier I, F-34000 Montpellier, France
关键词
cognition; Alzheimer's disease; estrogens; female reproductive cycle; menopause; hormone replacement therapy; cumulated lifelong exposure to steroids;
D O I
10.2174/138161205774913228
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aim of this review is to examine the relationship between endocrine fluctuation and cognitive functioning. A plethora of in vitro and in vivo studies has demonstrated the neuroprotective role of estrogens and their impact on the neurotransmitter systems implicated in cognition. Recent hormonal replacement therapy (HRT) trials in non-demented post-menopausal women suggest a temporary positive effect (notably on verbal memory), and four recent meta-analyses converge to suggest a possible protective effect in relation to Alzheimer's disease (reducing risk by 29 to 44%). However, data from the only large randomised controlled trial published to date, the Women's Health Initiative Memory Study, did not confirm these observations and have even suggested an increase in dementia risk for women using HRT compared to controls. Several methodological differences between observation studies and controlled trials with regard to patient group, type, timing and duration of HRT, cognitive measures and analyses, are discussed to explain these discrepancies. The association between hormonal serum level and cognitive functioning remains controversial suggesting high inter-individual vulnerability in risk. Moreover, research on the impact of endocrine functioning on cognition during the female reproductive cycle suggests life-long fluctuations in vulnerability. Etiological models taking into account the interaction of clinical, reproductive, and menstrual events throughout life may provide a more valid approach in understanding the effects of steroids on the brain and in determining sub-groups at heightened risk. Cognitive disorders in the elderly are more likely be related to cumulated lifelong exposure to steroids, rather than to a specific exposure to a given steroid. Multifactorial models based on an exhaustive view of all hormonal events throughout reproductive life together with other risk factors (notably genetic risk factors related to estrogen receptor polymorphisms) should be explored to clarify the role of hormonal risk factors, or protective factors for cognitive dysfunction and dementia.
引用
收藏
页码:4229 / 4252
页数:24
相关论文
共 233 条
[91]   Positive association between an estrogen receptor gene polymorphism and Parkinson's disease with dementia [J].
Isoe-Wada, K ;
Maeda, M ;
Yong, J ;
Adachi, Y ;
Harada, H ;
Urakami, K ;
Nakashima, K .
EUROPEAN JOURNAL OF NEUROLOGY, 1999, 6 (04) :431-435
[92]   HUMAN INTELLIGENCE - SEX-DIFFERENCES [J].
JARVIK, LF .
ACTA GENETICAE MEDICAE ET GEMELLOLOGIAE, 1975, 24 (3-4) :189-211
[93]   Estrogen receptor gene polymorphisms in patients with Alzheimer's disease, vascular dementia and alcohol-associated dementia [J].
Ji, Y ;
Urakami, K ;
Wada-Isoe, K ;
Adachi, Y ;
Nakashima, K .
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2000, 11 (03) :119-122
[94]   PATHOGENESIS OF OSTEOPOROSIS [J].
JOHNSTON, CC ;
SLEMENDA, CW .
BONE, 1995, 17 (02) :S19-S22
[95]   A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging [J].
Kawas, C ;
Resnick, S ;
Morrison, A ;
Brookmeyer, R ;
Corrada, M ;
Zonderman, A ;
Bacal, C ;
Lingle, DD ;
Metter, E .
NEUROLOGY, 1997, 48 (06) :1517-1521
[96]   Epidemiology of breast cancer [J].
Key, Timothy J. ;
Verkasalo, Pia K. ;
Banks, Emily .
LANCET ONCOLOGY, 2001, 2 (03) :133-140
[97]   ESTROGEN REPLACEMENT THERAPY MAY PROTECT AGAINST INTELLECTUAL DECLINE IN POSTMENOPAUSAL WOMEN [J].
KIMURA, D .
HORMONES AND BEHAVIOR, 1995, 29 (03) :312-321
[98]   Sex, sexual orientation and sex hormones influence human cognitive function [J].
Kimura, D .
CURRENT OPINION IN NEUROBIOLOGY, 1996, 6 (02) :259-263
[99]   Pros and cons of existing treatment modalities in osteoporosis:: a comparison between tibolone, SERMs and estrogen (±progestogen) treatments [J].
Kloosterboer, HJ ;
Ederveen, AGH .
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2002, 83 (1-5) :157-165
[100]   Can variability in the hormonal status of elderly women assist in the decision to administer estrogens? [J].
Kuchel, GA ;
Tannenbaum, C ;
Greenspan, SL ;
Resnick, NM .
JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE, 2001, 10 (02) :109-116